 BOSTON, May 02, 2022 GLOBE NEWSWIRE -- Decibel Therapeutics Nasdaq: DBTX, a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, announced today that it will present at the American Society of Gene and Cell Therapy ASGCT 25th Annual Meeting, being held virtually and in Washington D.C. May 15-19, 2022. 